Health Care & Life Sciences » Pharmaceuticals | Shionogi & Co. Ltd.

Shionogi & Co. Ltd.

Shionogi & Co. Ltd.
Stock Exchange Other OTC
EPS
$3.79
Market Cap
$18.08 B
Shares Outstanding
324.14 M
Public Float
-
Shionogi & Co. Ltd. ADR
Stock Exchange Other OTC
EPS
$0.95
Market Cap
$18.26 B
Shares Outstanding
1.27 B
Public Float
-
Shionogi & Co. Ltd.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
324.14 M
Public Float
-
Shionogi & Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY420.67
Market Cap
JPY1.97 T
Shares Outstanding
316.79 M
Public Float
252.87 M

Profile

Address
3-1-8 Dosho-machi
Osaka Osaka 541
Japan
Employees -
Website http://www.shionogi.co.jp
Updated 07/08/2019
Shionogi & Co., Ltd. engages in the research, development, supply, manufacture, and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.

Financials

View All
Created with Highcharts 5.0.14Shionogi & Co. Ltd.Net Income. Fiscal year is April-March. All values JPY Millions.41 83141 83144 06044 06066 68766 68783 87883 878108 866108 866132 759132 759201420152016201720182019025k50k75k100k125k150k
Created with Highcharts 5.0.14Shionogi & Co. Ltd.Sales/Revenue. Fiscal year is April-March. All values JPY Millions.289 717289 717273 991273 991309 973309 973338 890338 890344 667344 667363 721363 7212014201520162017201820190100k200k300k400k

Motozo Shiono
Chairman
Isao Teshirogi
President & Representative Director